Risk factor
# out of 3475 patients in the study (%)
Death
10 (0.3)
Deep wound infection
30 (1)
Cardiopulmonary complications
28 (1)
DVT
25 (0.7)
Pulmonary embolism
12 (0.4)
Cerebrovascular accident
3 (0.3)
Post-op neurologic deficit
5 (0.1)
Return to operating room
106 (3)
In a study of approximately 3,500 patients undergoing spinal reconstructive surgery abstracted from the National Surgical Quality Improvement database, there was a nearly 8 % complication rate. This included an infection rate of 1 % (30 deep wound infections), a mortality rate of 0.3 % (10 deaths) and cardiac complications of 1 %. There were an additional 37 VTE with a 0.4 % rate of pulmonary embolism (PE).The rate ofpostoperative neurologic deficits reported is0.1 % with 106 patients (3 %) requiring a return to the operating room. Clearly the rate of complications is significant, and both complication minimization and the informed consent process should be addressed with care [1]. Table 20.1 summarizes several risk factors and their influence mortality, one or more complications, and one or more major complications [1].
It is our protocol to obtain cardiac consultation in patients with significant prior cardiac history, including myocardial infarction or stent placement. If the suspicion is high enough for undiagnosed cardiac hypoperfusion, we will obtain a dobutamine stress echocardiography. Wall motion abnormalities and reversible ischemic defects can be identified, and when necessary cardiac revascularization via bypass grafting or stenting can be performed. Without a high index of suspicion, cardiac hypoperfusion may go undiagnosed until major spinal reconstruction surgery and demand ischemia may occur.
Surgical Site Infection Prevention
The surgical literature indicates that length of operation or operation requiring instrumentation of multiple vertebral levels is associated with an increased risk of postoperative infection [2]. Higher implant density is required with associated muscular dissection and longer retractor deployment with greater degree of tissue necrosis. However, even with less invasive surgical procedures, recolonization of the epidermis and wound occurs. Host flora begins to expand and multiply with locally occurring bacteria from a patient’s dermal adnexa, e.g., oil glands, hair follicles, and sweat glands. These bacteria recolonize over time even in relatively simple operations. The skin preparation is able to eradicate bacteria for only a limited period of time. Some surgeons advocate for re-prepping the skin at different time points during the case. However, it is clear that recolonization should be assumed for any case that lasts greater than 4 h [3].
To minimize the risk for surgical site infection, we have instituted several treatment strategies at our institution. In our patient population, we determine if patients are carriers of methicillin-resistant Staphylococcus aureus (MRSA) by preoperative nasal culture surveillance. For patients who have MRSA-positive nasal cultures, we prescribe Bactroban (mupirocin) as literature has found a reduction in postoperative SSI in patients who are treated with appropriate topical nasal antimicrobial therapy [4].
In an effort to reduce bacterial skin colonization, we begin topical skin prep with chlorhexidine gluconate skin towelettes beginning 3 days prior to operation. Preoperative skin preparation is first alcohol, followed by either a chlorhexidine or Betadine skin prep. We then administer a broad-spectrum anti-staphylococcal intravenous antibiotic dose within 1 h of skin incision (cefazolin or clindamycin) and may combine this with vancomycin for high-risk patients or procedures. Our guidelines have been accomplished with the assistance of infectious diseases physicians based upon the high prevalence of MRSA present in our community. At the conclusion of the operation and prior to placement of bone graft, we irrigate our posterior spine wounds with 4 L of dilute Betadine containing solution (3 % weight/volume) and then irrigate until clear with normal saline. This diminishes the bacterial counts in wounds which have been open for longer periods of time. We subsequently add 1–2 g of vancomycin powder (depending on wound size) prior to closure. Using the aforementioned procedures, we have been able to reduce our SSI over 50 % [5].
Pain Management
Adequate pain control is paramount not only to patient experience and satisfaction but also to early post-op ambulation and rehabilitation. These factors are closely linked to reduction of perioperative complications such as ileus, embolic events, and length of stay.
Efficacious pain protocols are variable among institutions; however, the need of standard protocols is paramount to delivering quality perioperative care to this patient population. Pain management is often complicated by long history of chronic pain and opiate dependence and necessitates individualized pain management regimes. The involvement of a proficient pain management team in the care of the most complicated patients is advised.
For chronic pain patients, an account of all analgesics being taken should be recorded and converted to IV morphine equivalents and noted in the preoperative assessment to facilitate intraoperative and postoperative pain requirements. Careful consideration should be given to patients with pain pumps. The type and dosage of the medication and the brand of the pump should be carefully noted. A pre-op CT scan should be considered to delineate the route of the catheter. Patients receiving opiates through their pumps need to be provided with equivalent preoperative medication dosing.
Surgeons must be particularly aware of the patients with intrathecal baclofen (ITB) pumps. Acute withdrawal of ITB may lead to a life-threatening syndrome of high fever, altered mental status, and profound muscular rigidity that may progress to fatal rhabdomyolysis. The definitive treatment for ITB withdrawal is the restoration of drug administration by the same route [6]. Surgeons must plan their surgical dissection by carefully studying the route of the catheter on pre-op CT scan to avoid severing the catheter and also plan of having catheter repair kits available in case it is damaged during the surgery. It is prudent to notify the device representative to be available if such issues arise.
Effective pain management protocols can be divided to the preoperative, intraoperative, and postoperative periods.
Preoperative
At our institution the following preoperative pain guidelines are used for patients undergoing large spinal deformity surgery. Preoperatively extended release opiates are used with attention to patient age: OxyContin 20 mg (<70yo), OxyContin 10 mg (70–80yo), and no OxyContin >80yo. Also gabapentin 900 mg oral liquid and IV tylenol 1000 mg are administered.
Gabapentin has been shown to be efficacious in reducing postoperative pain and narcotic requirements after spinal surgery, and in some studies there is evidence of up to 40 % reduction for additional postoperative pain treatment during the first 20 h [7, 8]. Also there is evidence for improved postoperative nausea and reduced incidence of vomiting/retching due to either the diminished need for postoperative opioids or due to the antiemetic effect of gabapentin itself. We continue gabapentin postoperatively at 300 mg QHS until the first postoperative visit.
Intraoperative
Ketamine
Acute pain management of patients with chronic pain who are opioid tolerant is often difficult.
In addition to traditional opioids such as fentanyl, remifentanil, sufentanil, Dilaudid, and morphine, ketamine should be considered as part of multimodal therapy for all patients with chronic pain who are undergoing spinal deformity surgery.
In a randomized controlled trial, intraoperative administration of ketamine reduced opioid consumption after spine surgery in patients with chronic pain who are opioid tolerant. The benefit of intraoperative ketamine did not have any apparent increase in side effects. Its mechanism of action is likely due to a combination of a reduction in central sensitization via NMDA receptor antagonism. Also ketamine has not been shown to have any deleterious effects on motor- or sensory-evoked potentials. Most protocols recommend ketamine 0.5 mg/kg as a bolus and then beginning a constant infusion at 0.1 mg/kg/h [8, 9].
Methadone
Recent studies have demonstrated efficacy in the perioperative administration of a single bolus of methadone before surgical incision. This resulted in a significant reduction of pain scores and reduced requirement of opioids in patients presenting for multilevel complex spine surgery. These patients continue to experience pain postoperatively, and the addition of a long-acting opioid such as methadone has been suggested as a safe alternative to a continuous infusion of short-acting opiates. Gottschalk et al. suggest that methadone (working as a combined opiate receptor agonist/N-methyl-D-aspartate receptor antagonist) may be an optimal drug for these patients given the probable involvement of N-methyl-D-aspartate systems in the mechanism of opioid tolerance and hyperalgesia. The dose and timing for this protocol would include administration of IV methadone (up to 0.2 mg/kg) following induction in opioid-tolerant patients [10].
Local Anesthetic Catheter
An additional modality includes intraoperative placement of local anesthetic delivering catheter, such as On-Q® PainBuster® ( I-Flow Corp., Lake Forest, CA). Long-acting anesthetics such as ropivacaine can be delivered at a controlled and adjustable rate and have been used with some success [11, 12].
Postoperative
Postoperative regimes include a combination of oral and parenteral opiates including PCA or nurse-controlled IV analgesia with conjunction of benzodiazepines to treat muscle spasms.
Postoperative pain medications are adjusted individually for opiate-tolerant patients and are usually done by calculating patients’ average opiate usage and prescribing the baseline dose in addition to our pain protocol. For example, a patient known to take an average of 40 mg of oxycodone will receive that amount in and extended release tablet in addition to their post-op pain medications.
Immediately after surgery patients are considered for patient-controlled analgesic (PCA) pump administering hydromorphone. Patients unable to use the pump are prescribed nurse-administered IV injections of hydromorphone in Q2–3 h increments based on their weight, age, and opiate naivety (see Table 20.2).
Table 20.2
Postoperative pain, diet, and VTE prophylaxis that can be considered for ASD patients (many of which are part of the ASD postoperative care protocol at our institution)
Pain | Diet/bowel | VTE Prophylaxis |
---|---|---|
Oxycodone 5 mg–15 mg q3h | Sips and ice chips to start | Sequential compressive devices (calf/ calf+foot) |
OxyContin 10 mg × 4 doses | Chewing gum | Lovenox 40 mg 48 h post-op |
Acetaminophen 1000 mg q6h | Clear liquid after flatus | Asa 81 mg qday × 3 weeks after discharge |
Gabapentin 300 mg QHS | Docusate 100 mg BID | For those going on flight within 2 months or going to SNF: Lovenox 40 mg 2 weeks post-op followed by asa 325 mg qday for 4 weeks |
As needed: Senokot, Dulcolax; milk of mag |
Spasmolytic medications are prescribed regularly and are very effective in controlling for muscle spasms. Consideration to the risks of respiratory depression when any of these medications are given in combination with opioids. Several options include baclofen 5–10 mg po TID prn for patients tolerating oral medications and tizanidine 2–4 mg po q 8–12 h. An IV alternative may be diazepam 1–2 mg IV TID prn muscle spasm [13].
NSAID use following spinal fusion has been discouraged in the adult population due to concerns regarding postoperative bleeding and pseudarthrosis. A retrospective study by Glassman in 1998 for adult patients found that NSAIDs have an adverse effect on fusion, with increase in nonunions for those that received IV ketorolac [14].
It is worth mentioning that several studies have demonstrated the efficacy and low risk of complications associated with IV NSAIDS following pediatric spine fusion [15]. Due to inconclusive evidence in the adult population, the authors recommend that NSAIDs be avoided in the early postoperative period, especially high-dose NSAIDs [16].
Bracing
There is scant evidence and clinical trials regarding postoperative brace use. Although many deformity surgeons brace their patients postoperatively, there is variability regarding the most appropriate type, duration, and indications for immobilization. With adult deformity reconstruction, the high rates of proximal junctional kyphosis (PJK) and proximal junctional failure (PJF) are significant concerns, and many surgeons attempt to protect their patients with postoperative orthosis. However, no evidence exists to support bracing influencing the incidence of PJK or PJF. Further prospective, clinical studies may play role in evaluating the efficacy of postoperative bracing protocols.